14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.14 $1.40 Friday, 3rd May 2024 ACRS stock ended at $1.36. This is 3.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.87% from a day low at $1.31 to a day high of $1.40.
90 days $1.05 $1.51
52 weeks $0.590 $11.12

Historical Aclaris Therapeutics prices

Date Open High Low Close Volume
Feb 23, 2023 $12.74 $13.09 $12.43 $12.77 1 109 033
Feb 22, 2023 $12.91 $13.13 $12.67 $12.69 829 246
Feb 21, 2023 $12.95 $13.20 $12.80 $12.83 632 474
Feb 17, 2023 $13.18 $13.33 $12.97 $13.13 596 168
Feb 16, 2023 $12.88 $13.36 $12.87 $13.08 1 100 210
Feb 15, 2023 $13.00 $13.25 $12.81 $13.09 1 465 529
Feb 14, 2023 $13.48 $13.57 $12.92 $13.25 1 214 154
Feb 13, 2023 $14.17 $14.53 $13.33 $13.53 604 535
Feb 10, 2023 $13.79 $14.32 $13.66 $14.29 1 192 135
Feb 09, 2023 $13.72 $14.13 $13.72 $13.86 890 847
Feb 08, 2023 $13.99 $14.41 $13.68 $13.72 731 868
Feb 07, 2023 $13.91 $14.16 $13.61 $14.08 931 857
Feb 06, 2023 $13.99 $14.17 $13.42 $13.73 1 089 934
Feb 03, 2023 $14.81 $15.25 $13.90 $14.05 1 890 024
Feb 02, 2023 $17.03 $17.61 $14.22 $14.33 1 991 082
Feb 01, 2023 $16.89 $17.15 $16.22 $16.97 650 028
Jan 31, 2023 $16.88 $17.51 $16.73 $16.90 472 620
Jan 30, 2023 $17.67 $18.54 $16.70 $16.85 448 703
Jan 27, 2023 $16.75 $17.68 $16.70 $17.48 1 016 459
Jan 26, 2023 $16.95 $17.10 $16.59 $16.82 402 417
Jan 25, 2023 $16.18 $16.98 $16.00 $16.77 496 682
Jan 24, 2023 $16.56 $16.83 $16.07 $16.40 473 206
Jan 23, 2023 $16.63 $16.68 $16.13 $16.59 323 449
Jan 20, 2023 $17.02 $17.02 $16.20 $16.65 306 644
Jan 19, 2023 $17.16 $17.16 $16.36 $16.68 239 201
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT